NL-OMON51323招募中3 期
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a multicenter randomized controlled trial - EMITT trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 238
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Informed consent, age >18-year-old
- •- Supratentorial localization
- •- Safe trajectory/trajectories possible for ablation of at least 70% of the
- •tumour, avoiding eloquent structures.
- •- Karnofsky Performance Status (KPS) >= 70
排除标准
- •- Contra-indication for general anaesthesia or MRI
- •- Non-glioblastoma diagnosis on pathology analysis
- •- No final pathology diagnosis available
- •- Pregnancy
研究者
相似试验
已完成
2 期
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a randomized pilot studybrain cancer10029211glioblastomaNL-OMON55122Radboud Universitair Medisch Centrum15
已完成
不适用
MR-guided LITT Therapy in Patients With Primary Irresectable GlioblastomaGlioblastomaNCT04596930Radboud University Medical Center15
已完成
不适用
Optimized Magnetic Resonance Imaging in patients with tongue cancersTongue cancer and normal subjectsJPRN-UMIN000024075Tokyo Medical and Dental University40
未知
不适用
Clinical study for Intensity Modulated RadiotherapyHepatic cancer, prostate cancer,brain, head and neck cancerJPRN-UMIN000000641Department of Radiology, Keio University5
已完成
不适用
Efficacy of MRI in primary care for patients with knee complaints due to traumaKnee injuriesknee compaints10043237NL-OMON41300Erasmus MC, Universitair Medisch Centrum Rotterdam360